Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations

Gut

Volumn 64, Issue 9, 2015, Pages 1379-1388

  Vicario, Maria ^a,b,c   Gonzàlez Castro, Ana M ^a,b   Martnez, Cristina ^d   Lobo, Beatriz ^a,b   Pigrau, Marc ^a,b   Guilarte, Mar ^b   De Torres, Inés ^b   Mosquera, Jose L ^e   Fortea, Marina ^a,b   Sevillano Aguilera, César ^a,b   Salvo Romero, Eloisa ^a,b   Alonso, Carmen ^a,b   Rodiño Janeiro, Bruno K ^a,b   Söderholm, Johan D ^f   Azpiroz, Fernando ^a,b,c   Santos, Javier ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF BARCELONA   (Spain)

^f LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN;

ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN PRODUCTION; IRRITABLE COLON; JEJUNUM DISEASE; MALE; MAST CELL; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY ATOPY; RESPIRATORY TRACT DISEASE; SIGNAL TRANSDUCTION; STRESS; UPREGULATION; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; COMPARATIVE STUDY; DISEASE COURSE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INTESTINE MUCOSA; JEJUNUM; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; NONPARAMETRIC TEST; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; T LYMPHOCYTE; TRANSMISSION ELECTRON MICROSCOPY; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; DIARRHEA; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; JEJUNUM; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84941299655     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-306236     Document Type: Article

References (47)

1. Martínez C, Vicario M, Ramos L, et al. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol 2012;107:736-46.
2. Martínez C, Lobo B, Pigrau M, et al. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut 2013;62:1160-8.
3. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004;4:953-64.
4. Matricon J, Meleine M, Gelot A, et al. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012;36:1009-31.
5. Foley S, Garsed K, Singh G, et al. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology 2011;140:1434-43. e1.
6. Reed DE, Barajas-Lopez C, Cottrell G, et al. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J Physiol 2003;547(Pt 2):531-42.
7. Cenac N, Andrews CN, Holzhausen M, et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007;117:636-47.
8. Barbara G, Wang B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007;132:26-37.
9. Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 2009;70:505-15.
10. Cerutti A, Chen K, Chorny A. Immunoglobulin responses at the mucosal interface. Annu Rev Immunol 2011;29:273-93.
11. Honjo T, Kinoshita K, Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol 2002;20:165-96.
12. Moisini I, Davidson A. BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol 2009;158:155-63.
13. Schoepfer AM, Schaffer T, Seibold-Schmid B, et al. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 2008;20:1110-18.
14. Öhman L, Lindmark AC, Isaksson S, et al. B-cell activation in patients with irritable bowel syndrome (IBS). Neurogastroenterol Motil 2009;21:644-50.
15. Zar S, Mincher L, Benson MJ, et al. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. Scand J Gastroenterol 2005;40:800-7.
16. Atkinson W, Sheldon TA, Shaath N, et al. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004;53:1459-64.
17. Ligaarden SC, Lydersen S, Farup PG. IgG and IgG4 antibodies in subjects with irritable bowel syndrome: a case control study in the general population. BMC Gastroenterol 2012;12:166.
18. Vivinus-Nébot M, Dainese R, Anty R, et al. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Am J Gastroenterol 2012;107:75-81.
19. Dunlop SP, Hebden J, Campbell E, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006;101:1288-94.
20. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
21. Guilarte M, Santos J, de Torres I, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007;56:203-9.
22. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997;11:395-402.
23. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32:920e4.
24. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-79.
25. Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Med 1967;11:213-18.
26. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-96.
27. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
28. Heinzerling L, Mari A, Bergmann KC, et al. The skin prick test-European standards. Clin Transl Allergy 2013;3:3.
29. Cerutti A, Zan H, Schaffer A, et al. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol 1998;160:2145-57.
30. Vicario M, Blanchard C, Stringer KF, et al. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 2010;59:12-20.
31. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008;3:1101-8.
32. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc B 1995;85:289-300.
33. Maindonald J, Braun J. Data analysis and graphics using R. 2nd edn. Cambridge: Cambridge University Press, 2007.
34. Magnusson J, Lin XP, Dahlman-Höglund A, et al. Seasonal intestinal inflammation in patients with birch pollen allergy. J Allergy ClinImmunol 2003;112:45-50.
35. Wu KC, Mahida YR, Priddle JD, et al. Immunoglobulin production by isolated intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1989;78:37-41.
36. Macpherson A, Khoo UY, Forgacs I, et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996;38:365-75.
37. Fagarasan S, Kinoshita K, Muramatsu M, et al. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 2001;413:639-43.
38. He B, Xu W, Santini PA, et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 2007;26:812-26.
39. He B, Santamaria R, Xu W, et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol 2010;11:836-45.
40. Lobo B, Vicario M, Martinez C, et al. Clinical benefit in IBS after disodium cromoglycate involves mast cell-mediated recovery of healthy-like innate immunity genes expression profile in the jejunal mucosa. Gastroenterology 2009;136(S1):30.
41. Sanderson IR, Walker WA. TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis. Am J Physiol Gastrointest Liver Physiol 2007;292: G6-10.
42. Carroll IM, Ringel-Kulka T, Keku TO, et al. Molecular analysis of the luminal-and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2011;301:G799-807.
43. Sachdev AH, Pimentel M. Antibiotics for irritable bowel syndrome: rationale and current evidence. Curr Gastroenterol Rep 2012;14:439-45.
44. Jefferis R, Kumararatne DS. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol 1990;81:357-67.
45. Kinoshita K, Harigai M, Fagarasan S, et al. A hallmark of active class switch recombination: transcripts directed by I promoters on looped-out circular DNAs. Proc Natl Acad Sci USA 2001;98:12620-3.
46. Coe CL, Rosenberg LT, Fischer M, et al. Psychological factors capable of preventing the inhibition of antibody responses in separated infant monkeys. Child Dev 1987;58:1420-30.
47. Cohen S, Miller GE, Rabin BS. Psychological stress and antibody response to immunization: a critical review of the human literature. Psychosom Med 2001;63:7-18.